Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abbreviated, abdominoplasty, accretion, activist, agenda, air, ANDA, Appendix, aqui, arm, Attorney, Austria, batch, Belgium, book, brain, bribery, broadening, budget, bunionectomy, categorized, central, certify, cGCP, CI, commonly, complicating, concert, consolidated, contest, Counterparty, deficiency, Denmark, discharge, dopamine, emission, encapsulated, entirety, equating, erythema, escalate, exacerbated, Excipient, Exhibit, experimental, facilitate, FactSet, Fast, FCA, Finland, France, gastrointestinal, Germany, Greece, heading, hereto, hernia, hoc, hypoxia, impede, inaccurate, increasingly, inguinal, inside, intestine, Ireland, Italy, IV, Jersey, judicial, Kingdom, labor, learn, logo, lost, lt, Luxembourg, MAGIC, malfeasance, misuse, molecule, move, movement, multimodal, netupitant, noncurrent, novelty, occupied, omitted, ordinary, paper, Paragraph, path, peripheral, pertinent, plc, portfolio, Portugal, potent, QD, qualification, reconsider, redesign, referenced, regimen, regularly, reinforce, repair, rolapitant, science, score, sensation, sensitive, shipment, short, Spain, SPI, static, stimulating, stolen, stratum, subsidized, substance, sue, Summed, surfactant, Sweden, Switzerland, tam, Tesaro, text, threat, threshold, tighten, tract, transition, transportation, treble, tumor, underwritten, undesirable, uninsured, unintended, VARUBI, vulnerable, waged, wholly, workforce, workplace, worst
Removed:
activate, addressing, advisory, affiliate, analytical, announced, ASC, aware, binding, bulk, called, center, chemotherapeutic, closed, Connecticut, consulting, consume, deny, destroy, detailed, direct, discontinued, discontinuing, filling, guaranty, gut, impacting, improve, Japan, lining, multicenter, neurotransmitter, obligated, October, prescribed, presently, referred, regular, releasing, Stamford, subsequently, threatening, unit
Filing tables
Filing exhibits
Related press release
HRTX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-190550, 333-195928 and 333-198862) and Form S-8 (Nos. 333-35151, 333-90428, 333-118546, 333-127574, 333-137954, 333-148660, 333-162610, 333-167515, 333-176365, 333-176366, 333-190549, 333-198853, 333-202588 and 333-206165) of Heron Therapeutics, Inc. of our reports dated February 18, 2016 relating to the consolidated financial statements and the effectiveness of Heron Therapeutics, Inc.’s internal control over financial reporting, which appear in this Annual Report on Form 10-K.
/s/ OUM & CO. LLP
San Francisco, California
February 18, 2016